Administer's Q1 results came in clearly below our expectations, with net sales declining 6% and EBITDA dropping sharply by 41% y/y. The miss was driven by unexpected weakness in Silta (customer contract terminations) and EmCe (delayed project starts), while cost savings have yet to flow through fully. Company issued FY26 guidance of EUR 105-115m net sales and EUR 6.5-9.0m EBITDA.
LÄS MER
